Gomez-Pan A, Tunbridge W M, Duns A, Hall R, Besser G M, Coy D H, Schally A V, Kastin A J
Clin Endocrinol (Oxf). 1975 Sep;4(5):455-60. doi: 10.1111/j.1365-2265.1975.tb01554.x.
The growth hormone response to the administration of the currently available synthetic hypothalamic hormones was assessed in eleven patients with acromegaly. Eight of them showed a positive GH response to thyrotrophin releasing hormone and three showed no response. The GH response to TRH was shown to be unrelated to the thyrotrophin response to TRH. The GH response to TRH was inhibited by the administration of growth hormone release inhibiting hormone. Luteinizing hormone/follicle stimulating hormone releasing hormone (LHRH) caused a positive GH response in four patients, but this was trivial in three. The TRH mediated GH release in acromegaly is not mediated via TSH and appears to be attributable to loss of specificity of the receptor sites on the somatotroph to the hypothalamic hormones.
对11例肢端肥大症患者给予目前可用的合成下丘脑激素后,评估了生长激素反应。其中8例对促甲状腺激素释放激素有阳性生长激素反应,3例无反应。生长激素对促甲状腺激素释放激素的反应与促甲状腺激素对促甲状腺激素释放激素的反应无关。生长激素释放抑制激素的给药可抑制生长激素对促甲状腺激素释放激素的反应。促黄体生成素/促卵泡激素释放激素(LHRH)在4例患者中引起阳性生长激素反应,但在3例中反应轻微。促甲状腺激素释放激素介导的肢端肥大症患者生长激素释放并非通过促甲状腺激素介导,似乎是由于生长激素细胞上的受体位点对下丘脑激素失去特异性所致。